childrens one-a-day
natures way (dublin) ltd - retinol thiamine hydrochloride riboflavin pyridoxine hydrochloride cyanocobalamin biotin folic acid nicotinic acid ascorbic acid colecalciferol tocopherol calcium iodine iron magnesium zinc - tablets
pediatric infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 4 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years
pediatric infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 4 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years
infuvite adult multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phos
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 200 mg in 10 ml - infuvite adult is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult is contraindicated in patients who have infuvite adult has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirements may exceed those of nonpregnant women. animal reproduction studies have not been conducted with infuvite adult. infuvite adult has not been studied in lactating women.lactating women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirement may exceed those of nonlactating women. caution should be exercised when infuvite adult is administered to a nursing mother. safety and effectiveness in children below the age of 11 years have not been establish
adult infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phos
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 200 mg in 10 ml - infuvite adult is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult is contraindicated in patients who have infuvite adult has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirements may exceed those of nonpregnant women. animal reproduction studies have not been conducted with infuvite adult. infuvite adult has not been studied in lactating women.lactating women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirement may exceed those of nonlactating women. caution should be exercised when infuvite adult is administered to a nursing mother. safety and effectiveness in children below the age of 11 years have not been establish
m.v.i. pediatric- ascorbic acid, retinol, ergocalciferol, thiamine hydrochloride, riboflavin 5-phosphate sodium, pyridoxine hydr
hospira, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91), ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), de - ascorbic acid 80 mg in 5 ml - m.v.i. pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. m.v.i. pediatric is contraindicated in patients who have: - a history of known hypersensitivity to any of the vitamins or excipients in m.v.i. pediatric [see warnings and precautions (5.2), adverse reactions (6)] - an existing hypervitaminosis the safety and effectiveness of m.v.i. pediatric for the prevention of vitamin deficiency have been established in pediatric patients up to 11 years of age receiving parenteral nutrition. the safety and effectiveness of m.v.i. pediatric have not been established in pediatric patients older than 11 years of age. m.v.i. pediatric contains aluminum that may be toxic for premature neonates. aluminum levels should be monitored periodically during administration of m.v.i. pediatric to p
pediatric infuvite multiple vitamins for infusion- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride,
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 5 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years
abidec multivitamin drops
omega pharma ltd - vitamin a palmitate; ergocalciferol; thiamine hydrochloride; riboflavin; pyridoxine hydrochloride; nicotinamide; ascorbic acid - oral drops - 2222unit/1ml ; 667unit/1ml ; 1.67mg/1ml ; 1333microgram/1ml ; 1333microgram/1ml ; 1333microgram/1ml ; 66.7mg/1ml
adult infuvite multiple vitamins for infusion- asorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, ribof
sandoz canada inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine - unii:x66nso3n35), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), d - ascorbic acid 200 mg in 10 ml - infuvite adult is indicated as a daily multivitamin maintenance supplement for adults and children aged 11 and older receiving parenteral nutrition. infuvite adult is also indicated in other situations where administration by the intravenous route is required. such situations include surgery, extensive burns, fractures and other trauma, severe infectious diseases, and comatose states, which may provoke a “stress” situation with profound alterations in the body’s metabolic demands and consequent tissue depletion of nutrients. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult (administered in intravenous fluids under proper dilution) contributes intake of necessary vitamins toward maintaining the body’s normal resistance and repair processes. patients with multiple vitamin deficiencies or with markedly increased requirements may be given multiples of the daily dosage for two or more days, as indicated by the clinical st
cernevit
remedix care ltd - ascorbic acid; biotin; cocarboxylase tetrahydrate; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; pyridoxine (vit b6) hydrochloride; retinol palmitate; riboflavine; tocopherol - powder for solution for injection - retinol palmitate 3500 iu/vial; colecalciferol 220 iu/vial; tocopherol 10.2 mg/vial; ascorbic acid 125 mg/vial; riboflavine 5.67 mg/vial; pyridoxine (vit b6) hydrochloride 5.5 mg/vial; cyanocobalamin 0.006 mg/vial; folic acid 0.414 mg/vial; dexpanthenol 16.15 mg/vial; biotin 0.069 mg/vial; nicotinamide 46 mg/vial; cocarboxylase tetrahydrate 5.8 mg/vial - combinations - combinations - vitamin supplementation in patients receiving parenteral nutrition. only for adults and children over 11 years of age.